global
world
knowledg
import
infecti
diseas
essenti
daili
practic
microbiologistparasitologist
clinician
diagnos
treat
infecti
diseas
return
travel
tropic
subtrop
countri
greater
risk
contract
infecti
diseas
among
frequent
visit
tourist
destin
seimc
consid
appropri
produc
consensu
document
use
primari
care
doctor
well
specialist
intern
medicin
infecti
diseas
tropic
medicin
help
treat
travel
return
tropic
subtrop
area
infect
prevent
aspect
infecti
diseas
infect
import
immigr
explicitli
exclud
sinc
dealt
seimc
document
variou
type
profession
clinician
microbiologist
parasitologist
help
produc
consensu
document
evalu
avail
evidencebas
data
order
propos
seri
key
fact
inform
individu
aspect
topic
first
section
document
summari
gener
aspect
overal
evalu
travel
return
home
potenti
infect
main
second
section
contain
key
fact
caus
agent
diagnost
procedur
therapeut
measur
associ
major
infecti
syndrom
affect
return
travel
gastrointestin
syndrom
acut
persist
diarrhea
febril
syndrom
obviou
sourc
infect
local
cutan
lesion
respiratori
infect
indic
final
characterist
special
type
travel
pregnant
women
immunocompromis
travel
describ
accompani
document
extens
bibliographi
form
basi
recommend
articl
inform
intern
travel
enfermedad
infecciosa
importada
tra
el
regreso
de
viaj
en
el
extranjero
documento
de
consenso
de
la
sociedad
de
enfermedad
infecciosa
seimc
en
el
mundo
global
el
conocimiento
de
la
enfermedad
infecciosa
importada
es
esenci
en
la
diaria
tanto
para
el
como
para
el
en
enfermedad
infecciosa
que
atienden
viajero
internacional
entr
lo
destino
visitado
se
encuentran
mucho
tropical
subtropical
dond
el
riesgo
de
contraer
una
enfermedad
infecciosa
es
elevado
la
seimc
ha
considerado
pertinent
la
de
un
documento
de
consenso
que
sirva
de
ayuda
tanto
de
primaria
como
lo
especialista
en
medicina
interna
enfermedad
infecciosa
medicina
tropic
que
atienden
viajero
que
regresan
con
infeccion
tra
un
viaj
zona
tropical
subtropical
se
han
excluido
de
forma
lo
aspecto
de
de
la
misma
la
infeccion
importada
por
inmigrant
objeto
de
otro
documento
de
la
seimc
vario
tipo
de
profesional
han
desarrollado
est
documento
de
consenso
evaluando
lo
dato
dispon
basado
en
la
evidencia
para
propon
una
seri
de
dato
clave
acerca
de
est
aspecto
inicialment
se
revisan
lo
aspecto
general
acerca
de
la
gener
del
viajero
que
regresa
con
una
potenci
en
un
segundo
bloqu
se
lo
dato
clave
agent
causal
procedimiento
medida
de
lo
infeccioso
principal
en
el
viajero
que
regresa
gastrointestin
diarrea
aguda
persistent
el
febril
sin
foco
aparent
la
lesion
localizada
la
infeccion
respiratoria
finalment
se
describen
la
en
viajero
especial
como
la
viajera
embarazada
el
viajero
inmunodeprimido
est
documento
se
de
la
correspondient
que
fundamenta
esta
recomendacion
palabra
clave
enfermedad
infecciosa
importada
pubm
databas
perform
use
follow
select
criteria
articl
publish
march
english
spanish
limit
human
search
term
use
travel
associ
item
explor
eg
fever
diarrhea
search
complement
review
cochran
databas
systemat
review
use
travel
key
term
also
intern
guidelin
deal
separ
aspect
evalu
search
conduct
use
prisma
criteria
review
contributor
first
instanc
coordin
text
version
total
public
select
elimin
duplic
relev
specif
set
refer
select
section
may
request
contributor
accord
world
tourism
organ
around
million
intern
tourist
arriv
million
increas
intern
tourist
arriv
year
forecast
increas
worldwid
region
region
growth
expect
highest
asia
pacif
america
follow
europ
africa
middl
east
familitur
data
show
intern
tourist
movement
made
spaniard
million
african
contin
america
central
caribbean
south
asia
frequent
visit
tourist
destin
includ
tropic
subtrop
countri
higher
risk
contract
infecti
diseas
travel
econom
less
develop
countri
frequent
involv
exposur
biolog
agent
caus
infect
infecti
diseas
transmit
differ
rout
digest
respiratori
mucocutan
vector
one
point
highlight
outset
possibl
infect
intern
travel
could
also
caus
cosmopolitan
agent
found
within
countri
exampl
would
sexual
transmit
diseas
std
set
infecti
condit
insuffici
studi
among
travel
differenti
diagnosi
therefor
alway
includ
diseas
restrict
geograph
distribut
well
global
presenc
furthermor
sever
clinic
pictur
present
vari
good
deal
special
section
includ
manag
serious
ill
patient
final
certain
situat
physiolog
pregnanc
patholog
natur
exampl
immunocompromis
patient
whether
associ
hiv
infect
special
characterist
warrant
discuss
medic
point
view
guidelin
use
primari
care
physician
well
specialist
intern
medicin
infecti
diseas
tropic
medicin
treat
travel
return
tropic
subtrop
area
infect
target
popul
document
adult
infect
import
return
intern
travel
prevent
import
diseas
infect
import
immigr
explicitli
exclud
sinc
consid
recent
eimc
review
also
left
gener
sens
noninfecti
ill
among
travel
although
certain
aspect
indic
specif
section
variou
type
profession
clinician
microbiologist
parasitologist
help
produc
consensu
document
evalu
evidencebas
inform
avail
make
recommend
follow
aspect
systemat
review
bibliographi
perform
evalu
data
concern
caus
diagnost
method
therapeut
option
infect
import
travel
search
assess
need
applic
resuscit
procedur
secondli
patient
evalu
presenc
sepsi
septic
shock
use
establish
criteria
assign
score
use
sever
diseas
classif
system
respect
sapsii
score
system
good
predictor
mortal
malaria
patient
apach
iv
scale
use
worldwid
riskadjust
mortal
rate
icu
length
stay
perform
associ
travelrel
ill
pilgrim
attend
hajj
specif
studi
seriou
caus
import
diseas
travel
case
studi
involv
febril
syndrom
lesser
extent
respiratori
problem
common
febril
diagnosi
p
falciparum
malaria
follow
typhoid
fever
leptospirosi
rickettsi
infect
dengu
also
diagnos
less
often
infrequ
patient
malaria
also
infect
complic
malaria
pneumonia
cholecyst
bacteremia
main
seriou
respiratori
condit
associ
respiratori
distress
malaria
pneumonia
infect
coronavirus
common
travel
diarrhea
give
rise
seriou
condit
although
symptom
may
manifest
clinic
context
ill
potenti
sever
skin
diseas
manifest
petechi
lesion
purpura
gener
accompani
fever
viral
hemorrhag
fever
mening
blister
diseas
stevensjohnson
syndrom
import
patholog
depend
region
countri
visit
date
travel
whether
appropri
antimalaria
chemoprophylaxi
vaccin
given
prior
departur
type
travel
behavior
aquat
activ
consumpt
contamin
food
etc
mention
previous
complementari
test
request
use
diagnos
caus
rational
travel
diarrhea
occur
context
travel
character
three
bowel
movement
looser
usual
within
period
number
bowel
movement
accompani
least
one
follow
nausea
vomit
abdomin
pain
fever
convent
call
acut
diarrhea
last
less
day
persist
diarrhea
last
longer
clinic
data
use
assess
sever
diarrhea
henc
mild
diarrhea
defin
fewer
three
bowel
movement
per
day
fever
blood
fece
moder
diarrhea
defin
three
bowel
movement
absenc
fever
blood
fece
sever
diarrhea
defin
presenc
signific
dehydr
sign
suggest
tissu
invas
fever
blood
stool
acut
travel
diarrhea
trigger
ingest
food
water
contamin
pathogen
microorgan
common
occurr
among
travel
estim
risk
experienc
diarrhea
episod
twoweek
stay
depend
destin
characterist
travel
although
diarrhea
episod
acut
selflimit
proport
affect
suffer
may
develop
persist
gastrointestin
symptom
accord
recent
review
frequent
identifi
etiolog
agent
decreas
order
etec
enterotoxigen
e
coli
eaec
enteroaggreg
e
coli
enteroadher
e
coli
noroviru
rotaviru
salmonella
spp
campylobact
jejuni
shigella
spp
aeromona
spp
plesiomona
shigelloid
enterotoxigen
bacteroid
fragili
vibrio
spp
variou
seri
caus
agent
identifi
standard
method
case
gener
effect
empir
antibiot
therapi
shorten
durat
ill
patient
seem
suggest
predomin
etiolog
diarrhea
bacteri
case
stool
cultur
neg
clinic
practic
high
proport
diarrhea
neg
stool
cultur
due
enterobacteria
identifi
convent
method
less
commonli
virus
clostridium
difficil
andor
parasit
although
latter
frequent
implic
persist
travel
diarrhea
geograph
variat
respect
caus
agent
systemat
systemat
review
longstay
travel
expatri
militari
servic
personnel
also
found
region
differ
etiolog
diarrhea
thu
southeast
asia
preval
etec
rel
low
higher
campylobact
spp
salmonella
spp
compar
region
hand
pathogen
frequent
identifi
latin
america
caribbean
middl
east
subsaharan
africa
etec
import
rememb
system
infect
travel
malaria
dengu
arbovirus
well
enter
fever
typhoid
paratyphoid
fever
may
initi
present
diarrhea
adequ
rule
anyon
present
acut
travel
diarrhea
fever
see
section
diagnost
test
travel
diarrhea
normal
reserv
patient
present
fever
temperatur
blood
fece
dysenteri
choleriform
diarrhea
accompani
degre
dehydr
well
occur
immunosuppress
patient
major
comorbid
microbiolog
diagnost
method
choic
stool
cultur
yield
favor
result
stool
liquid
unform
complement
blood
cultur
fever
convent
stool
cultur
offer
good
yield
salmonella
spp
shigella
spp
pathogen
requir
select
media
campylobact
spp
yersinia
spp
vibrio
spp
therefor
essenti
notifi
microbiologist
clinic
suspicion
identif
variou
pathotyp
ecoli
involv
acut
travel
diarrhea
enterotoxigen
e
coli
ecet
enteroaggreg
e
coli
eaec
virus
especi
noroviru
foodborn
diseas
bacillu
cereu
staphylococcu
aureu
routin
avail
diagnos
refer
laboratori
use
new
molecular
techniqu
simultan
detect
analysi
multipl
pathogen
pcrbase
multiplex
assay
capabl
identifi
microorgan
singl
assay
well
evalu
acut
diarrhea
method
attract
option
term
increas
sensit
convent
method
present
disadvantag
interpret
final
select
case
analyt
test
may
use
fecal
marker
detect
intestin
inflamm
methylen
blue
dye
fecal
leukocyt
lactoferrin
releas
leukocyt
fecal
occult
blood
test
fobt
andor
fecal
calprotectin
system
inflamm
differenti
white
blood
cell
count
erythrocyt
sediment
rate
esr
creactiv
protein
crp
invas
ventricular
assist
devic
vad
well
basic
biochemistri
monitor
dehydr
renal
function
fluidelectrolyt
imbal
acut
travel
diarrhea
health
problem
impair
qualiti
life
travel
accompani
caus
disrupt
travel
plan
activ
manag
peculiar
sens
appear
princip
context
countri
whose
medic
sanitari
resourc
drug
steril
measur
minim
difficult
find
compli
standard
water
food
hygien
rule
advic
well
chemoprophylaxi
specif
case
may
help
prevent
acut
travel
diarrhea
travel
set
also
necessari
indic
main
mean
selftreat
diarrhea
trip
travel
also
advis
high
fever
intens
abdomin
pain
blood
diarrhea
uncontrol
vomit
selfmed
prove
effect
hesh
seek
medic
assist
persist
reach
destin
therapeut
measur
base
test
previous
indic
selftreat
acut
travel
diarrhea
three
basic
compon
rehydr
symptomat
treatment
antibiot
use
measur
depend
sever
diarrhea
patient
characterist
r
e
h
r
n
basic
compon
therapi
acut
travel
diarrhea
mild
case
less
vulner
patient
healthi
adult
liquid
contain
salt
sugar
help
maintain
hydrat
specif
loperamid
ad
differ
oral
rehydr
solut
convent
liquid
moder
case
peopl
greater
risk
children
old
peopl
peopl
chronic
ill
oral
rehydr
therapi
ort
use
commerci
homemad
prepar
indic
commerci
sold
prepar
hypoton
formula
less
sodium
glucos
content
caus
less
vomit
fewer
bowel
movement
effect
standard
formul
anoth
option
consist
prepar
litr
water
ad
lemon
juic
salt
half
coffe
spoon
bicarbon
half
coffe
spoon
sugar
coffe
spoon
isoton
drink
aim
sportsmen
recommend
contain
suffici
concentr
electrolyt
sever
case
intraven
rehydr
use
replac
fluid
electrolyt
respect
diet
oral
hydrat
start
advis
go
four
hour
without
food
mucos
recoveri
enhanc
small
frequent
intak
food
rich
energi
micronutri
throughout
day
rice
pasta
meat
fruit
veget
u
e
f
antidiarrh
medic
restrict
noninvas
diarrhea
without
fever
blood
stool
two
commonli
use
agent
loperamid
racecadotril
loperamid
inhibit
motil
intestin
secret
administ
mild
diarrhea
combin
nonabsorb
antibiot
diarrhea
sever
taken
symptom
improv
improv
within
h
maximum
day
loperamid
alon
increas
risk
acquir
extendedspectrum
betalactamas
bacteria
racecadotril
inhibit
intestin
enkephalinas
reduc
intestin
secret
without
alter
motil
efficaci
travel
diarrhea
systemat
evalu
use
antimicrobi
therapi
consid
care
weigh
advantag
disadvantag
among
advantag
shorten
durat
diarrhea
sever
day
prevent
complic
reactiv
arthriti
syndrom
postinfecti
irrit
bowel
syndrom
main
disadvantag
cost
sideeffect
alter
qt
interv
macrolid
musculoskelet
complic
quinolon
risk
colon
multidrugresist
enterobacteria
drug
use
fall
two
group
nonabsorb
rifaximin
absorb
quinolon
macrolid
rifaximin
nonabsorb
antibiot
activ
nonenteroinvas
strain
e
coli
good
safeti
profil
given
children
year
old
symptom
improv
rapidli
combin
loperamid
two
drug
administ
separ
clinic
trial
demonstr
util
new
formul
rifamycin
colontarget
deliveri
although
date
data
efficaci
gener
recommend
antibiot
treatment
fluoroquinolon
two
three
day
although
singl
dose
ciprofloxacin
may
enough
fluoroquinolon
activ
princip
enteropathogen
bacteria
although
southeast
asia
increas
resist
report
basic
shigella
spp
campylobact
spp
etec
fluoroquinolon
contraind
pregnant
women
children
also
predispos
clostridium
difficil
overgrowth
caus
persist
diarrhea
singl
mg
dose
azithromycin
effect
threeday
regimen
also
effect
threeday
regimen
levofloxacin
drawback
may
nausea
first
minut
h
e
r
measur
potenti
use
selfmed
antiemet
metoclopramid
domperidon
ondansetron
interact
metoclopramid
atovaquoneproguanil
malaria
chemoprophylaxi
note
use
probiot
lactobacillu
acidophilu
saccharomyc
boulardii
associ
reduc
frequenc
durat
diarrhea
although
studi
heterogen
recommend
although
persist
travel
diarrhea
less
common
pose
greater
challeng
diagnosi
may
appear
trip
continu
recur
may
may
accompani
digest
symptom
abdomin
pain
bloat
weight
loss
malabsorpt
system
one
asthenia
lowgrad
fever
practic
point
view
three
possibl
caus
infecti
caus
socal
postinfecti
syndrom
exist
previou
concomit
chronic
gastrointestin
diseas
diagnos
travel
start
estim
infecti
caus
persist
diarrhea
involv
less
final
diagnos
case
common
infecti
caus
persist
travel
diarrhea
parasit
specif
protozoan
diarrhea
associ
clostridium
difficil
occasion
caus
enterobacteria
empir
therapi
initi
stool
cultur
bacteria
prolong
incub
period
potenti
resist
antimicrobi
commonli
use
acut
diarrhea
three
commonli
recogn
protozoan
parasit
giardia
intestinali
entamoeba
histolytica
cryptosporidium
homini
follow
three
less
common
one
dientamoeba
fragili
cyclospora
cayetanensi
risk
cyclospora
greatest
countri
nepal
peru
haiti
guatemala
cystoisospora
isospora
belli
sarcocysti
spp
balantidium
coli
caus
dysenteri
differ
speci
microsporidia
enterocytozoon
bieneusi
encephalitozoon
intestinali
c
belli
microsporidia
play
major
role
chronic
diarrhea
hivinfect
patient
socal
postinfecti
syndrom
compris
heterogen
group
function
alter
intestin
motil
persist
fluctuat
intestin
secret
trigger
previou
intestin
infect
travel
includ
four
main
entiti
transient
lactos
intoler
postinfecti
irrit
bowel
syndrom
small
intestin
bacteri
overgrowth
sibo
tropic
sprue
often
sever
possibl
diagnos
group
condit
addit
chronic
intestin
diseas
celiac
diseas
young
patient
microscop
coliti
older
adult
common
transient
lactos
intoler
especi
children
typic
good
clinic
correl
intens
symptom
abdomin
pain
wateri
diarrhea
nausea
abdomin
bloat
andor
flatul
underli
degre
malabsorpt
key
symptom
sine
qua
non
diagnosi
postinfecti
irrit
bowel
syndrom
piib
pain
persist
recurr
abdomin
discomfort
togeth
chang
bowel
habit
predominantli
diarrhea
syndrom
specif
one
microorgan
particular
describ
follow
bacteri
infect
due
shigella
spp
campylobact
spp
salmonella
spp
recent
follow
infect
etec
produc
heatlabil
toxin
well
viral
protozoan
infect
entamoeba
histolytica
giardia
spp
cryptosporidium
spp
dientamoeba
fragili
littl
known
pathogenesi
probabl
multifactori
one
realli
certain
true
incid
piib
among
travel
cohort
swiss
travel
suffer
episod
travel
diarrhea
develop
piib
follow
month
given
diagnosi
piib
fundament
clinic
symptombas
episod
travel
diarrhea
exacerb
preexist
irrit
bowel
syndrom
travel
critic
obtain
detail
gastrointestin
statu
patient
travel
tropic
sprue
entiti
without
definit
etiolog
occur
certain
tropic
subtrop
geograph
area
guid
symptom
nutrient
malabsorpt
clinic
spectrum
may
simul
anyth
piib
celiac
diseas
littl
known
pathogenesi
entiti
essenti
describ
incid
may
underestim
view
grow
number
sporad
case
report
recent
year
larg
affect
longterm
resid
expatri
tropic
area
within
degre
north
south
equat
particularli
preval
southern
india
indonesia
philippin
papua
new
guinea
although
also
describ
northern
part
south
america
caribbean
west
africa
diagnost
method
choic
intestin
parasit
examin
stool
least
three
sampl
recommend
prefer
altern
day
collect
period
day
given
intermitt
fecal
excret
diagnost
form
ideal
examin
includ
least
direct
smear
examin
fresh
stool
sampl
stain
lugol
iodin
solut
examin
concentr
fece
prepar
sediment
trichrom
stain
anoth
perman
stain
protozoa
requir
special
techniqu
stain
modifi
acidfast
stain
safranin
kinyoun
fluoresc
microscopi
cryptosporidium
spp
cyclospora
spp
fluoresc
modifi
trichrom
stain
microsporidi
spore
mean
laboratori
notifi
suspect
techniqu
detect
antigen
stool
specimen
enzym
immunoassay
eia
direct
fluorescentantibodi
dfa
giardia
intestinali
cryptosporidium
spp
entamoeba
histolytica
detect
identif
viru
genom
stool
pcr
entamoeba
spp
dientamoeba
fragili
give
increas
sensit
compar
convent
method
enabl
entamoeba
histolytica
differenti
e
dispar
exampl
otherwis
pathogen
morpholog
indistinguish
blastocysti
homini
cyst
frequent
identifi
chronic
diarrhea
remain
controversi
topic
interpret
nonpathogen
commens
without
therapeut
indic
although
serv
marker
confirm
oralfec
contamin
presenc
unidentifi
underli
parasit
nonetheless
given
presenc
symptom
reason
rule
caus
agent
therapeut
trial
may
attempt
diagnost
method
helminthiasi
associ
persist
diarrhea
indic
section
diarrhea
associ
clostridium
difficil
suspect
travel
receiv
recent
antimicrobi
treatment
mainli
fluoroquinolon
even
true
incid
travel
communityacquir
c
difficil
infect
like
prior
histori
antimicrobi
contact
healthcar
system
may
therefor
help
spread
hypervirul
strain
unknown
use
elisa
detect
toxin
fecal
specimen
low
sensit
despit
speed
high
specif
detect
antigen
stool
specimen
glutam
dehydrogenas
quick
higher
sensit
tend
use
screen
test
subsequ
confirm
cultur
pcr
sinc
detect
c
difficil
clinic
sampl
alway
equat
diseas
diagnosi
continu
challeng
clinician
laboratori
final
recent
studi
suggest
tropheryma
whipplei
caus
organ
whippl
diseas
involv
travel
diarrhea
although
larger
appropri
design
studi
requir
usual
diagnost
method
transient
lactos
intoler
evalu
clinic
respons
strict
lactosefre
diet
minimum
day
week
result
unclear
primari
intoler
hypolactasia
suspect
function
test
use
standard
lactos
toler
test
tend
replac
hydrogen
h
breath
test
hbt
lactos
specif
sensit
gaxilos
test
sensit
specif
less
avail
determin
lactas
enzym
activ
small
intestin
biopsi
materi
effici
invas
complic
rare
use
practic
genet
diagnosi
detect
c
variant
cc
genotyp
g
variant
gg
genotyp
lactas
lct
promot
region
correl
well
primari
hypolactasia
could
provid
noninvas
diagnost
altern
entiti
diagnosi
piib
requir
variou
data
tabl
patient
fulfil
clinic
criteria
base
symptom
chronolog
accord
recent
modifi
rome
iv
criteria
specif
piib
sensit
less
ii
organ
function
process
exclud
iii
appear
de
novo
previous
asymptomat
patient
episod
acut
infecti
diarrhea
diarrhea
fever
posit
stool
cultur
evalu
piib
complex
gener
uncertainti
doctor
well
patient
basic
aspect
given
data
shown
tabl
pretest
probabl
organ
diseas
less
without
requir
complementari
explor
ultrasound
gastrointestin
barium
studi
colonoscopi
andor
oral
endoscopi
biopsi
tissu
sampl
ii
care
follow
criteria
doctor
patient
feel
sure
organ
diseas
avoid
factiti
ill
munchhausen
syndrom
delusion
intestin
parasitosi
iii
patient
inform
favour
life
prognosi
well
tendenc
symptom
improv
slowli
steadili
iv
necessari
use
object
techniqu
posit
diagnosi
syndrom
respect
commerci
avail
serolog
test
ibschek
commonwealth
laboratori
base
detect
antibodi
cdtb
cytoleth
distend
toxin
b
produc
gramneg
bacteria
specif
sensit
close
diagnosi
irrit
bowel
syndrom
although
valid
small
intestin
bacteri
overgrowth
diagnos
use
lactulos
dglucos
hydrogen
breath
test
dxylos
breath
test
altern
therapeut
test
antibiot
exampl
tetracyclin
week
last
resort
quantit
bacteri
count
cultur
proxim
jejun
aspir
characterist
find
bacteri
overgrowth
low
serum
level
elev
level
folic
acid
due
consumpt
product
respect
bacteri
overgrowth
schill
test
use
determin
rate
vitamin
absorpt
show
whether
bodi
absorb
vitamin
normal
cours
antibiot
therapi
diagnosi
tropic
sprue
requir
criteria
indic
tabl
differenti
diagnosi
celiac
diseas
histolog
test
antibodi
hla
essenti
final
thorough
clinic
histori
pretravel
digest
symptom
may
guid
toward
gastrointestin
diseas
previous
undiagnos
unmask
travel
mainli
inflammatori
bowel
diseas
celiac
diseas
primari
hypolactasia
microscop
coliti
collagen
lymphocyt
context
treatment
etiolog
infect
pathogen
postinfecti
syndrom
high
suspicion
parasit
infect
time
regardless
neg
test
result
author
recommend
cours
empir
treatment
nitroimidazol
metronidazol
tinidazol
giardia
spp
frequent
protozoan
parasit
caus
persist
diarrhea
travel
caus
agent
common
caus
fever
unknown
origin
return
travel
order
frequenc
malaria
arboviru
eg
dengu
chikungunya
zika
bacteri
infect
typhoid
fever
rickettsi
infect
q
fever
leptospirosi
aii
even
though
rare
seriou
diseas
highli
contagi
viral
hemorrhag
fever
eg
ebola
lassa
marburg
rift
valley
fever
crimeancongo
hemorrhag
fever
alway
consid
ciii
origin
travel
period
incub
specif
risk
exposur
provid
guidanc
etiolog
febril
process
aii
travel
present
fever
unknown
origin
visit
tropic
subtrop
area
seek
immedi
medic
attent
aii
risk
vhf
malaria
rule
first
instanc
use
microscopi
techniqu
rapid
diagnost
test
aii
acut
phase
arboviru
suspect
day
clinic
evolut
patient
test
presenc
antigen
viral
rna
blood
urin
aii
diagnosi
bacteri
infect
respons
fever
unknown
origin
base
acut
phase
isol
bacteri
organ
use
molecular
biolog
techniqu
later
phase
serolog
studi
pair
serum
sampl
aii
treatment
etiolog
symptomat
base
identifi
caus
agent
aii
high
probabl
malaria
diagnosi
made
delay
hour
altern
diagnosi
administr
empir
antimalari
therapi
recommend
aii
patient
like
diagnosi
sever
acut
schistosomiasi
neuroschistosomiasi
treat
corticosteroid
combin
praziquantel
bii
complic
sever
case
malaria
use
ceftriaxon
plu
doxycyclin
recommend
wait
confirm
diagnosi
ciii
fever
unknown
origin
refer
high
bodi
temperatur
suggest
detail
patient
medic
travel
histori
sign
local
involv
physic
explor
lymphadenopathi
visceromegali
widespread
cutan
lesion
consid
local
data
situat
relat
import
syndrom
caus
may
also
cosmopolitan
infect
infecti
problem
variou
case
seri
involv
travel
tropic
subtrop
countri
incid
fever
unknown
origin
febril
process
nonspecif
selflimit
also
reckon
specif
diagnosi
reach
third
patient
present
fever
travel
main
caus
order
frequenc
malaria
travel
visit
malari
area
ii
infect
due
certain
exot
virus
particularli
dengu
chikungunya
zika
iii
bacteri
infect
typhoid
fever
rickettsi
infect
q
fever
leptospirosi
less
common
diagnos
brucellosi
acut
schistosomiasi
katayama
fever
african
trypanosomiasi
viscer
leishmaniasi
recurr
fever
due
borrelia
spp
primari
hiv
infect
final
although
rare
seriou
highli
contagi
diseas
viral
hemorrhag
fever
exampl
ebola
lassa
marburg
rift
valley
fever
crimeancongo
hemorrhag
fever
alway
consid
detail
medic
travel
histori
taken
anyon
seek
medic
advic
present
fever
unknown
origin
follow
travel
exhaust
physic
explor
carri
initi
orient
import
know
geograph
area
visit
incub
period
differ
diseas
specif
risk
associ
travel
respect
geograph
area
fundament
caus
fever
travel
africa
especi
subsaharan
region
malaria
specif
malaria
caus
p
falciparum
travel
asia
latin
america
howev
dengu
malaria
caus
infect
speci
involv
signific
number
case
incub
period
differ
infecti
diseas
also
use
diagnosi
incub
period
malaria
least
day
maximum
period
depend
speci
respons
month
year
tropic
virus
dengu
chikungunya
zika
agent
respons
vhf
maximum
incub
period
day
rule
except
produc
hantavirus
figur
show
typic
incub
period
infect
associ
import
fever
unknown
origin
also
import
discov
specif
risk
associ
individu
travel
henc
mosquito
bite
associ
malaria
main
import
virus
except
viscer
leishmaniasi
insect
bite
bedbug
flea
tick
vector
spread
diseas
endem
african
trypanosomosiasi
rickettsi
infect
borreliosi
drink
unpasteur
milk
may
mean
transmiss
brucellosi
q
fever
freshwat
contact
endem
area
could
epidemiolog
factor
involv
leptospirosi
schistosomiasi
final
riski
sexual
contact
lead
consid
possibl
hiv
infect
malaria
caus
import
fever
unknown
origin
sever
import
characterist
major
caus
type
fever
travel
subsaharan
africa
africa
highest
malari
burden
fall
southeast
asia
america
main
caus
agent
seri
plasmodium
falciparum
follow
p
vivax
p
malaria
p
oval
final
seri
note
travel
whose
reason
travel
visit
friend
rel
vfr
risk
acquir
malaria
stay
longer
prophylaxi
inadequ
took
fewer
precautionari
measur
protect
global
term
three
exot
viral
diseas
caus
dengu
chikungunya
zika
virus
spread
primarili
aed
mosquito
emerg
caus
fever
unknown
origin
recent
decad
signific
growth
dengu
flaviviru
caus
fever
unknown
origin
travel
current
common
malaria
travel
southeast
asia
america
nevertheless
preval
seriou
form
less
epidem
outbreak
eastcentralsouth
african
ecsa
asian
genotyp
given
rise
outbreak
initi
centr
countri
border
indian
ocean
kenya
comoro
island
reunion
island
subsequ
spread
southward
southeast
asia
region
europ
caribbean
south
america
spain
case
chikungunya
viru
infect
import
caribbean
dominican
republ
haiti
venezuela
colombia
h
e
zika
viru
flaviviru
also
known
sinc
increasingli
common
diagnos
variou
speci
rickettsia
spp
coxiella
burnetti
caus
fever
unknown
origin
diseas
link
outdoor
activ
contact
anim
arthropod
bite
main
agent
involv
travel
infect
rickettsia
africa
africa
r
conorii
mediterranean
orientia
tsutsugamushi
asia
rickettsia
typhi
anoth
caus
bacteri
infect
fever
unknown
origin
travel
leptospirosi
caus
l
interrogan
tend
appear
travel
involv
water
activ
raft
swim
notifi
frequent
male
southeast
asia
africa
caribbean
suspect
case
viral
hemorrhag
fever
appropri
biosecur
measur
implement
result
recent
ebola
viru
epidem
ebov
west
africa
diagnost
criteria
clear
algorithm
diagnos
ebov
infect
establish
extend
vhf
diagnosi
basic
detect
viral
genom
blood
serum
detect
rna
mean
pcr
preced
onestep
revers
transcript
rtpcr
sampl
manipul
inactiv
class
iii
biolog
safeti
cabinet
diagnost
work
carri
biosafeti
level
iv
laboratori
although
level
iii
also
permit
easytoimpl
immunochromatograph
techniqu
provid
rapid
diagnosi
report
confirm
would
requir
commerci
kit
develop
marburg
congocrimean
virus
rift
valley
fever
detect
identif
lassa
pose
problem
viru
present
high
degre
genet
variabl
simpl
method
avail
interpret
result
malaria
first
possibl
caus
fever
obviou
sourc
travel
return
endem
area
use
rememb
classic
aphor
patient
return
endem
area
must
assum
malaria
proven
otherwis
techniqu
diagnos
malaria
recent
revis
publish
eimc
summari
main
techniqu
thick
blood
smear
sensit
thin
blood
smear
make
easier
identifi
caus
speci
malaria
stain
stain
giemsa
techniqu
requir
skill
microscopist
ii
malaria
rapid
diagnost
test
rdt
detect
specif
antigen
produc
malaria
parasit
provid
simpl
rapid
diagnosi
nevertheless
give
falseneg
result
determin
plasmodium
speci
quantifi
parasitemia
evalu
respons
treatment
iii
pcr
high
sensit
detect
mix
infect
also
lowlevel
parasitemia
iv
serolog
techniqu
use
diagnos
acut
malaria
gener
arbovir
diseas
detect
use
direct
method
rtpcr
antigen
detect
case
dengu
fever
viru
specif
posit
first
day
onset
fever
mean
ii
serolog
test
sensit
less
specif
serolog
crossreact
drawback
turn
posit
day
onset
symptom
may
neg
time
consult
recommend
therefor
take
whole
blood
andor
serum
sampl
first
day
direct
techniqu
also
worthwhil
take
urin
sampl
zika
viru
flavivirus
west
nile
sinc
viru
detect
longer
mean
day
onset
symptom
specif
antibodi
detect
especi
igm
elisa
ifa
high
specif
posit
case
confirm
later
neutral
antibodi
test
detect
zika
viru
problemat
commerci
avail
test
valid
incomplet
typhoid
fever
diagnos
mainli
identifi
caus
agent
blood
cultur
possibl
bone
marrow
stool
cultur
isol
subcultur
biochem
test
agglutin
specif
antisera
typic
necessari
identifi
serovar
malditof
method
use
serolog
widal
test
anoth
use
test
measur
agglutin
antibodi
serum
flagellar
h
lipopolysaccharid
antigen
salmonella
typhi
although
low
specif
apart
two
classic
approach
elisa
techniqu
rapid
test
pcr
develop
although
none
higher
specif
sensit
two
describ
n
h
e
c
e
f
rickettsi
infect
q
fever
serolog
method
base
ifa
elisa
wide
use
recommend
although
born
mind
may
possibl
detect
antibodi
respons
acut
phase
better
collect
two
sampl
week
apart
confirm
diagnosi
fourfold
greater
increas
antibodi
titer
two
combin
pcr
techniqu
acut
phase
help
provid
accur
diagnosi
use
laboratori
test
diagnos
leptospirosi
vari
depend
phase
ill
acut
phase
direct
test
use
detect
leptospir
leptospir
antigen
andor
nucleic
acid
blood
andor
urin
leptospir
visibl
darkfield
phasecontrast
microscopi
although
techniqu
use
diagnosi
low
sensit
specif
serolog
test
pcr
order
offer
higher
sensit
neg
serolog
result
acut
phase
rule
diseas
pair
serum
sampl
requir
first
taken
first
day
infect
second
day
later
respect
serolog
test
microscop
agglutin
test
mat
common
way
diagnos
leptospirosi
requir
mainten
rang
serotyp
cultur
continu
use
confirmatori
test
also
commerci
elisa
kit
differenti
igg
igm
pose
healthcar
risk
oper
sinc
requir
handl
live
microorgan
rapid
immunochromatograph
test
increasingli
use
allow
rapid
diagnosi
good
sensit
specif
f
r
entiti
diagnost
method
use
autochthon
case
fever
nonspecif
symptom
one
earliest
manifest
minor
ill
well
potenti
fatal
one
return
travel
fever
never
disregard
dismiss
hand
even
symptom
patient
present
fever
unknown
origin
main
object
recogn
rule
diseas
high
morbimort
rate
exampl
malaria
typhoid
fever
repres
threat
public
health
viral
hemorrhag
fever
tuberculosi
etc
appli
therapeut
measur
isol
precaut
appropri
case
rather
reach
diagnost
certainti
everi
case
applic
specif
isol
precaut
manag
sever
ill
patient
indic
previous
see
section
treatment
malaria
recent
revis
publish
eimc
import
rememb
treatment
choic
sever
malaria
except
first
trimest
pregnanc
dose
mgkg
intraven
artesun
mgkg
children
kg
hour
schedul
intraven
artesun
minimum
schedul
dose
must
follow
day
oral
artemisininbas
combin
therapi
dihydroartemisininpiperaquin
artemetherlumefantrin
case
patient
sever
ill
high
probabl
malaria
ie
splenomegali
platelet
count
hemoglobin
gdl
diagnosi
made
would
delay
hour
recommend
absenc
diagnosi
give
patient
empir
treatment
malaria
gener
term
principl
malaria
treatment
follow
sever
malaria
distinguish
malaria
without
sever
criteria
ii
import
identifi
caus
parasit
possibl
consid
p
falciparum
iii
essenti
discov
geograph
area
infect
acquir
sinc
key
determin
possibl
resist
particular
antimalari
drug
iv
quantif
parasitemia
essenti
v
except
first
trimest
pregnanc
use
artemisinin
deriv
oral
intraven
rout
prefer
fast
act
quinin
vi
case
p
vivax
p
oval
final
cours
primaquin
given
end
complet
cure
erad
hypnozoit
case
defici
patient
first
rule
treatment
main
arbovirus
dengu
chikungunya
zika
symptomat
use
acetylsalicyl
acid
avoid
drug
choic
typhoid
fever
leptospirosi
ceftriaxon
day
day
respect
azithromycin
altern
option
patient
allerg
betalactam
doxycyclin
drug
choic
treat
rickettsi
infect
q
fever
recommend
durat
treatment
vari
accord
speci
acut
schistosomiasi
katayama
syndrom
diseas
requir
special
consider
treatment
earli
stage
recommend
avoid
clinic
manifest
prevent
complic
associ
chronic
infect
prevent
neuroschistosomiasi
drug
choic
praziquantel
dose
mgkg
depend
speci
combin
corticosteroid
administ
either
simultan
shortli
corticosteroid
treatment
praziquantel
repeat
month
sinc
drug
effect
young
migrat
schistosomula
n
hemorrhag
fever
support
care
sometim
option
although
case
hemorrhag
fever
caus
arenavirida
bunyavirida
lassa
fever
congocrimean
hemorrhag
viru
ribavirin
initi
within
first
day
ill
mortal
rate
reduc
treatment
consist
load
dose
mgkg
ribavirin
administ
intraven
maximum
g
follow
mgkg
intraven
maximum
gdose
everi
hour
day
mgkg
intraven
maximum
mgdose
everi
hour
day
antilassa
fever
plasma
may
use
adjunct
therapi
ill
patient
final
serious
ill
patient
wait
cultur
serolog
result
empir
use
ceftriaxon
doxycyclin
recommend
treat
main
bacteri
caus
fever
unknown
origin
primari
morpholog
lesion
eg
papul
pustul
nodul
ulcer
blister
configur
eg
linear
distribut
expos
versu
cover
area
specif
part
bodi
help
diagnosi
aii
case
diagnosi
clinic
dermoscopi
use
entiti
scabi
cutan
larva
migran
furuncular
myiasi
tungiasi
biii
import
dermatosi
develop
slowli
cutan
leishmaniasi
mycobacteri
infect
subcutan
mycosi
suspect
histolog
examin
identif
caus
agent
mean
molecular
biolog
techniqu
mass
spectrometri
essenti
aii
mani
import
dermatos
treatment
symptomat
oral
antihistamin
diphenhydramin
hydroxyzin
loratadin
topic
antiprurit
calamin
lotion
topic
corticosteroid
low
potenc
genit
medium
potenc
trunk
extrem
aii
treatment
choic
main
import
dermatos
linear
pattern
cutan
larva
migran
ctm
cutan
larva
curren
gnathostomiasi
ivermectin
albendazol
altern
option
ai
surgic
remov
associ
antibacteri
antitetanu
chemoprophylaxi
appropri
treatment
choic
furuncular
myiasi
tungiasi
repen
infect
aii
local
skin
lesion
one
main
reason
return
travel
seek
medic
advic
consider
variat
time
appear
sinc
manifest
travel
shortli
return
much
later
depend
caus
agent
sever
cosmopolitan
skin
lesion
tabl
dermoscopi
may
use
diagnos
scabi
cutan
larva
migran
furunculoid
myiasi
tungiasi
first
diagnost
possibl
eosinophilia
helminth
infect
see
section
circumst
biopsi
lesion
tissu
histolog
examin
molecular
biolog
techniqu
andor
mass
spectrometri
essenti
etiolog
diagnosi
leishmaniasi
nontubercul
mycobacteria
n
mani
import
dermatos
treatment
symptomat
oral
antihistamin
diphenhydramin
hydroxyzin
loratadin
topic
antiprurit
therapi
calamin
lotion
topic
corticosteroid
low
potenc
genit
medium
potenc
trunk
extrem
seriou
case
oral
corticosteroid
may
use
prednison
prednisolon
case
treatment
base
etiolog
use
filariasi
gnathostomiasi
leishmaniasi
atyp
mycobacteria
etc
surgic
remov
treatment
choic
furuncular
myiasi
tungiasi
repen
infect
mammal
bite
essenti
assess
need
tetanu
prophylaxi
rabi
immunoprophylaxi
rabiesendem
area
use
prophylact
antibiot
usual
amoxicillinclavulan
moxifloxacin
acyclovir
indic
prevent
herp
b
infect
monkey
bite
especi
old
world
macaqu
cercari
dermat
also
known
swimmer
itch
worldwid
distribut
although
concentr
countri
africa
immun
reaction
caus
cercaria
larva
variou
schistosoma
speci
includ
bird
schistosom
trichobilharzia
spp
transmit
unbroken
skin
come
contact
freshwat
contamin
larva
approxim
half
hour
later
urticari
rash
appear
expos
area
especi
leg
feet
becom
seabath
erupt
exanthema
break
hour
swim
saltwat
especi
caribbean
atlant
usa
brazil
pacif
coast
oceania
southeast
asia
associ
etiologicallyspeak
toxin
inject
skin
sting
cell
nematocyst
sea
anemon
edwardsiella
lineata
thimbl
jellyfish
linuch
unguiculata
lesion
similar
produc
cercari
dermat
although
differenti
fact
seabath
erupt
occur
area
skin
cover
swimsuit
subject
pressur
diagnosi
base
clinic
suspicion
epidemiolog
histopatholog
skin
biopsi
show
nonspecif
perivascular
interstiti
inflammatori
infiltr
rash
gener
resolv
week
treatment
symptomat
use
therapi
mention
previous
infect
differ
speci
filari
nematod
infrequ
caus
skin
lesion
cutan
larva
curren
name
given
one
characterist
cutan
manifest
infect
caus
strongyloid
stercorali
infect
nematod
occur
bare
skin
come
contact
ground
contamin
larva
parasit
consid
present
infrequ
travel
differenti
diagnosi
made
comparison
highli
prurit
linear
lesion
cutan
larva
migran
gnathostomiasi
sparganosi
base
speed
progress
rapid
local
abdomen
back
shoulder
absenc
subcutan
hemorrhag
skin
biopsi
littl
use
diagnosi
base
usual
techniqu
parasit
see
section
treatment
choic
ivermectin
consecut
day
given
week
apart
albendazol
hour
day
altern
option
cutan
larva
migran
caus
uncinaria
nematod
parasit
commonli
found
cat
dog
skin
biopsi
allow
speciesspecif
diagnosi
high
sensit
specif
standard
serolog
test
intraderm
montenegro
test
use
diagnos
cutan
mucocutan
leishmaniasi
travel
treatment
complex
optim
patient
treat
individu
basi
refer
speci
geographi
host
aspect
lesion
local
experi
drug
avail
cost
advers
effect
mani
case
cutan
leishmaniasi
resolv
spontan
almost
two
third
patient
treat
local
therapi
heat
therapi
topic
paromomycin
intralesion
inject
antimoni
cryotherapi
complic
cutan
case
system
treatment
oral
azol
fluconazol
ketoconzol
itraconazol
miltefosin
use
treatment
mucocutan
leishmaniasi
administ
parenter
first
choic
pentaval
antimoni
amphotericin
b
miltefosin
altern
option
gener
cutan
lesion
associ
marin
environ
includ
seabath
erupt
refer
infrequ
import
due
coral
fish
stonefish
stingray
jellyfish
bacteri
infect
term
coral
use
taxonom
mean
refer
marin
invertebr
class
anthozoa
typic
live
coloni
polyp
coral
lesion
caus
product
multipl
toxin
gener
involv
pain
pruritu
erythema
coral
wound
clean
possibl
debrid
dilut
vinegar
appli
reduc
pain
characterist
lesion
caus
coral
heal
slowli
due
persist
inorgan
matter
calcium
carbon
organ
matter
nematocyst
bacteri
superinfect
two
main
type
fish
caus
skin
lesion
travel
stonefish
stingray
n
cutan
lesion
due
saltwat
contact
could
infecti
treat
antimicrobi
effect
enterobacteria
halophil
microorgan
eg
vibrio
spp
quinolon
andor
tetracyclin
myiasi
infest
dermi
develop
larva
variou
fli
speci
within
arthropod
order
diptera
two
frequent
form
travel
furuncular
myiasi
caus
larva
dermatobia
homini
cordylobia
anthropophaga
fli
live
humid
area
lay
egg
abdomen
mosquito
bloodsuck
arthropod
insect
bite
host
includ
human
egg
hatch
larva
penetr
skin
tissu
period
week
furuncular
lesion
develop
sensat
movement
within
central
open
larva
breath
also
elimin
serosanguin
discharg
frass
case
develop
treatment
conserv
involv
block
breath
hole
petroleum
jelli
order
kill
larva
within
extract
appli
manual
pressur
round
lesion
furuncl
grown
certain
size
topic
use
ivermectin
kill
larva
enabl
releas
advanc
case
larva
must
extract
surgic
method
furuncular
myiasi
due
cordylobia
anthropophaga
tumbu
fli
tutsi
fli
mango
fli
commonest
form
africa
pregnant
fli
lay
egg
wet
cloth
outsid
dwell
egg
hatch
garment
worn
larva
burrow
skin
apart
geographi
lesion
caus
cordylobia
spp
distinguish
sever
way
associ
dermatobia
spp
frequent
multipl
ii
incub
period
shorter
day
iii
larva
smaller
size
iv
lesion
frequent
affect
part
bodi
cover
garment
larva
smaller
lesion
deep
usual
possibl
use
conserv
method
extract
larva
case
clinic
diagnosi
made
dermoscopi
may
help
two
common
form
superfici
cutan
mycos
travel
two
type
piedra
black
piedra
white
piedra
tinea
nigra
affect
outer
layer
skin
hair
involv
signific
inflamm
two
type
piedra
character
hard
nodul
hair
shaft
two
main
varieti
distinguish
basi
caus
agent
geograph
locat
part
bodi
affect
diagnosi
base
morpholog
characterist
infect
hair
treat
koh
solut
fungal
cultur
hair
normal
harmless
infect
although
may
present
social
problem
unpleas
underarm
odour
treatment
base
shave
affect
area
use
topic
treatment
ketoconazol
shampoo
oral
therapeut
option
avail
recur
case
subcutan
fungal
infect
rare
among
travel
although
case
sporotrichosi
chromoblastomycosi
lobomycosi
mycetoma
describ
frequent
skin
lesion
among
travel
due
bite
compris
almost
consult
due
dermatosi
although
distribut
worldwid
insect
bite
especi
common
travel
tropic
area
common
associ
arthropod
exampl
mosquito
flea
tick
bedbug
spider
clinic
manifest
highli
vari
mosquito
bite
exampl
manifest
wheal
papul
bulla
diagnosi
suggest
presenc
central
punctum
lesion
flea
bite
gener
give
rise
papul
often
group
three
characterist
featur
bitten
tick
presenc
black
necrot
lesion
black
eschar
tach
noir
common
travel
south
africa
bite
bed
bug
pain
caus
chancr
discharg
serosanguin
fluid
special
form
call
dermat
lineari
associ
travel
tropic
region
raini
season
caus
beetl
paederu
subtrib
fire
bug
commonli
manifest
sting
intens
pain
pruritu
later
develop
erythemat
plaqu
blister
linear
array
appear
hour
follow
contact
major
case
diagnosi
clinic
biopsi
necessari
doubt
case
treatment
symptomat
oral
antihistamin
may
given
good
deal
pruritu
topic
corticosteroid
calamin
lotion
possibl
vectorborn
diseas
transmiss
alway
consid
tungiasi
inflammatori
skin
infect
caus
femal
flea
tunga
penetran
ectoparasit
penetr
epidermi
parasit
infest
skin
preval
latin
america
caribbean
subsaharan
africa
flea
infect
poultri
dog
cat
rat
pig
occasion
human
be
habitat
dri
soil
sand
egg
deposit
subsequ
hatch
male
flea
die
copul
human
gravid
femal
penetr
skin
gener
feet
space
toe
round
nail
burrow
epidermi
feed
blood
host
case
lesion
singl
white
papul
form
halo
dark
brownishblack
spot
center
seven
ten
day
femal
lay
egg
daili
small
open
abdomin
caviti
die
shortli
afterward
complet
cycl
diagnosi
base
clinic
histori
patient
includ
prior
travel
endem
area
riski
practic
morpholog
local
lesion
dermoscopi
may
use
diagnosi
distinguish
featur
radial
crown
pigment
peripher
ring
black
pore
center
treatment
choic
surgic
remov
entir
flea
curettag
caviti
well
tetanu
prophylaxi
secondari
infect
frequent
symptom
respiratori
infect
travel
affect
upper
respiratori
tract
iii
viral
follow
bacteri
pathogen
commonest
caus
respiratori
infect
fungi
parasit
much
rarer
iv
studi
welldesign
methodolog
observ
travel
fever
respiratori
symptom
present
viral
infect
influenza
rhinoviru
coronaviru
respiratori
syncyti
viru
rsv
adenoviru
human
metapneumoviru
hmpv
v
influenza
viru
commonest
caus
respiratori
infect
travel
also
prevent
vaccin
although
incid
depend
seri
season
factor
exampl
recent
pandem
bacteri
caus
also
consid
aureu
system
involv
pulmonari
thromboembol
pulmonari
toxic
due
mefloquin
clinic
histori
fundament
guid
diagnosi
return
travel
respiratori
symptom
case
ill
mild
selflimit
medic
advic
health
center
sought
diagnost
test
necessari
pneumonia
howev
seriou
respiratori
infect
travel
especi
risk
factor
chronic
diseas
ill
immunosuppress
advanc
age
pneumonia
account
case
requir
posttravel
admiss
hospit
fever
icu
admiss
death
mean
diagnost
effort
treatment
concentr
patient
chest
xray
continu
gold
standard
pneumonia
diagnosi
case
travel
recommend
test
use
select
subset
patient
fever
cough
leukocytosi
elev
creactiv
protein
level
fever
without
clear
obviou
diagnosi
imag
techniqu
cat
scan
chest
may
use
defin
radiograph
pattern
pneumonia
evalu
complic
possibl
make
etiolog
diagnosi
use
clinic
present
basic
analysi
imag
techniqu
furthermor
even
use
appropri
techniqu
possibl
make
microbiolog
diagnosi
half
case
systemat
studi
microbiolog
diagnost
test
travelrel
pneumonia
although
recommend
initi
use
usual
techniqu
microorgan
global
distribut
account
episod
clinic
suspicion
abnorm
analyt
sign
eosinophilia
specif
geograph
destin
riski
activ
travel
studi
extend
direct
test
tabl
molecular
techniqu
use
diagnos
common
virus
emerg
virus
endem
fungal
infect
potenti
seriou
system
infect
enter
fever
dengu
leptospirosi
malaria
specif
diagnost
test
recommend
describ
section
specif
studi
treatment
travelrel
respiratori
infect
first
decis
made
patient
concern
need
hospit
implement
isol
precaut
upper
respiratori
infect
requir
hospit
case
pneumonia
sever
scale
use
determin
whether
autochthon
patient
admit
gener
ward
icu
appli
patient
without
sever
criteria
risk
factor
treat
outpati
basi
emerg
servic
indic
antibiot
therapi
guid
clinic
judgment
procalcitonin
level
help
reduc
antibiot
use
without
increas
risk
complic
return
patient
respiratori
infect
isol
airborn
precaut
recommend
patient
admit
hospit
tuberculosi
droplet
precaut
mycoplasma
pneumonia
bordetella
pertussi
diphtheria
melioidosi
influenza
adenoviru
syncyti
respiratori
viru
merscov
symptomat
treatment
suffici
travelrel
respiratori
infect
use
analges
antipyret
antiinflammatori
decongest
cough
suppress
antihistamin
bronchodil
target
antibiot
treatment
howev
indic
upper
respiratori
infect
pharyng
due
streptococcu
pyogen
diphtheria
whoop
cough
antiretrovir
acut
hiv
infect
absenc
associ
clinic
suspicion
empir
therapi
pneumonia
similar
administ
autochthon
patient
clinic
analyt
epidemiolog
suspicion
tropic
diseas
antibiot
treatment
pneumonia
travel
initi
provid
coverag
typic
bacteria
global
distribut
found
communityacquir
pneumonia
howev
given
greater
incid
infect
due
legionella
spp
reason
use
regimen
includ
levofloxacin
macrolid
treatment
base
identifi
caus
pathogen
present
differenti
featur
patient
influenza
admit
hospit
present
factor
involv
risk
complic
earli
treatment
oseltamivir
zanamivir
recommend
first
hour
tropic
infect
melioidosi
requir
variou
combin
antibiot
administ
intraven
follow
lengthi
period
oral
antibiot
travel
acquir
tuberculosi
area
high
incid
resist
reason
consid
treatment
least
drug
perform
rapid
sensit
test
xpert
order
adjust
therapi
result
mild
case
primari
deep
mycos
requir
treatment
symptom
seriou
case
drug
choic
amphotericin
b
itraconazol
becom
chronic
helminth
infect
requir
target
therapi
well
corticosteroid
case
acut
schistosomiasi
syndrom
patient
present
import
eosinophilia
nonfilari
etiolog
import
rule
infect
due
parasit
princip
helminth
aii
patient
import
eosinophilia
caus
identifi
parasit
case
bii
three
frequent
found
parasit
infect
strongyloidiasi
schistosomiasi
soiltransmit
helminth
infect
well
filariasi
case
equatori
guinea
bii
return
travel
eosinophilia
request
stool
examin
search
parasit
use
concentr
method
strongyloid
stercorali
serolog
bii
empir
anthelmint
treatment
administ
patient
receiv
clinic
followup
monitor
peripher
blood
eosinophil
count
sinc
parasit
like
trichuri
spp
schistosoma
spp
develop
resist
lead
anthelmint
treatment
failur
aii
diagnost
workup
import
eosinophilia
one
complex
challeng
clinic
practic
import
diseas
main
reason
parasitolog
test
low
sensit
serolog
test
low
specif
accord
seri
analyz
parasit
caus
identifi
high
percentag
case
depend
center
characterist
patient
similar
figur
found
children
import
eosinophilia
diagnost
yield
studi
involv
travel
notic
less
perform
immigr
publish
seri
strongyloidiasi
schistosomiasi
soiltransmit
helminth
infect
ascariasi
trichuriasi
ancylostomiasi
common
parasit
caus
depend
patient
statu
immigr
travel
proven
filariasi
major
suspect
caus
patient
gulf
guinea
equatori
guinea
cameroon
eosinophilia
caus
helminth
infect
gener
mild
selflimit
nevertheless
estim
travel
return
tropic
area
eosinophilia
could
potenti
seriou
infect
consequ
health
also
contact
prompt
appropri
effort
made
determin
etiolog
travel
present
import
eosinophilia
sinc
helminth
involv
caus
addit
morbid
sometim
mortal
case
toxocariasi
strongyloidiasi
caus
eosinophilia
identifi
roughli
case
travel
import
eosinophilia
screen
begin
exhaust
clinic
histori
serv
prompt
addit
test
studi
main
epidemiolog
aspect
emphas
addit
touchscreen
questionnair
document
symptom
accompani
eosinophilia
fever
diarrhea
pruritu
respiratori
neurolog
problem
help
lead
definit
diagnosi
thorough
physic
examin
made
detect
lesion
skin
soft
tissu
eye
enlarg
abdomin
organ
respiratori
involv
complement
basic
analyt
studi
includ
complet
blood
count
blood
chemistri
determin
liver
muscl
enzym
basic
studi
renal
function
initi
evalu
highli
use
lead
etiolog
diagnosi
physic
explor
indic
sign
symptom
abnorm
imag
test
carri
exampl
chest
xray
ultrasound
scan
abdomin
ct
scan
tabl
clinic
inform
complement
test
parasit
base
geograph
proven
travel
sinc
endem
area
certain
parasit
diseas
regionspecif
wherea
other
cosmopolitan
seen
tabl
strongyloid
filari
parasit
schistosom
fasciola
spp
solium
e
granulosu
iv
mani
serolog
method
perform
special
center
caus
eosinophilia
highli
suspect
determin
use
diagnost
test
previous
outlin
import
repeat
direct
parasit
test
sinc
test
neg
onset
infect
elimin
egg
scant
intermitt
tabl
indic
prepat
period
length
migratori
phase
princip
helminth
prepat
period
period
infect
parasit
appear
blood
tissu
form
egg
larva
accordingli
stool
examin
egg
larva
neg
period
clearli
caus
eosinophilia
identifi
target
treatment
given
anthelmint
choic
travel
present
eosinophilia
etiolog
diagnosi
made
test
empir
treatment
indic
intervent
strategi
base
good
safeti
profil
anthelmint
avail
enhanc
effect
easeofus
oral
regimen
studi
evalu
effect
empir
therapi
import
eosinophilia
posit
respons
report
patient
unexplain
eosinophilia
treat
empir
albendazol
therapi
day
anoth
studi
carri
among
subsaharan
immigr
eosinophilia
resolv
receiv
empir
therapi
ivermectin
albendazol
praziquantel
ivermectin
key
drug
use
empir
manag
import
eosinophilia
sinc
object
treat
strongyloidiasi
chronic
diseas
infect
human
host
decad
caus
sever
dissemin
diseas
deadli
case
especi
involv
immunosuppress
furthermor
ivermectin
also
effect
parasit
difficult
diagnos
gnathostoma
spp
empir
therapi
import
eosinophilia
preclud
investig
nonimport
caus
eosinophilia
potenti
seriou
hematolog
disord
neoplasia
assum
disappear
eosinophil
patient
receiv
empir
therapi
sign
caus
agent
elimin
born
mind
howev
eosinophilia
alway
follow
consist
cours
lead
error
necessari
monitor
eosinophilia
caus
administ
anthelmint
therapi
major
caus
persist
infect
parasit
resist
drug
choic
case
schistosomiasi
possibl
present
associ
caus
agent
fetu
final
use
prophylact
therapeut
measur
pregnant
woman
present
special
characterist
collabor
obstetrician
infecti
diseas
specialist
microbiolog
refer
laboratori
requir
infect
pregnant
woman
suscept
infect
transmit
food
water
decreas
gastric
acid
output
slower
intestin
movement
alter
immun
respons
system
result
higher
incid
travel
diarrhea
pregnant
women
specif
infect
listeriosi
typhoid
fever
also
frequent
found
subgroup
vectorborn
infect
malaria
common
pregnant
women
associ
higher
co
emiss
increas
bodi
temperatur
howev
data
indic
increas
frequenc
arbovirus
dengu
zike
pregnant
women
data
higher
incid
infect
transmit
rout
respiratori
via
contact
water
soil
popul
respect
group
infect
spread
via
gastrointestin
tract
pregnant
women
develop
travel
diarrhea
gastrointestin
infect
may
vulner
dehydr
acidemia
increas
risk
prematur
birth
pregnant
woman
listeriosi
gener
mild
infect
one
carri
high
risk
complic
fetu
typhoid
fever
pregnanc
associ
higher
incid
diarrhea
liver
dysfunct
gastrointestin
bleed
intestin
perfor
mother
well
increas
miscarriag
fetal
loss
case
fetal
loss
occur
mother
shown
symptom
five
day
without
receiv
treatment
henc
earli
diagnosi
appropri
treatment
improv
prognosi
fetu
overal
term
infect
due
hepat
viru
sever
pregnanc
although
isol
case
fulmin
hepat
third
trimest
well
increas
risk
uterin
contract
prematur
labour
fetal
death
transplacent
transmiss
rare
although
transmit
neonat
childbirth
infect
hepat
e
viru
associ
high
morbid
mortal
mother
fetu
morbid
form
acut
liver
failur
hemorrhag
diathesi
kidney
failur
acquir
third
trimest
pregnanc
much
frequent
gener
popul
matern
mortal
also
much
higher
gener
popul
babi
becom
infect
transmiss
perinat
intrauterin
infant
mortal
f
vectorborn
infect
import
malaria
particularli
due
p
falciparum
acquir
pregnanc
present
special
characterist
associ
higher
risk
complic
mother
sever
anemia
hypoglycemia
acut
respiratori
distress
syndrom
ard
lead
death
patient
ii
associ
miscarriag
prematur
birth
low
birthweight
perinat
death
iii
preval
vfr
travel
autochthon
travel
iv
diagnosi
pregnanc
may
difficult
parasit
sequest
placenta
reduc
parasitemia
peripher
blood
pcr
use
diagnost
tool
pregnanc
sinc
identifi
parasitemia
threshold
microscopi
v
women
without
immun
higher
rate
congenit
malari
infect
onset
symptom
week
birth
yellow
fever
seem
seriou
pregnanc
studi
suggest
dengu
infect
may
predispos
certain
complic
chiefli
toward
end
pregnanc
higher
matern
mortal
preeclampsia
high
rate
caesarean
section
prematur
birth
low
birthweight
low
rate
transplacent
infect
fetu
may
minim
affect
sinc
protect
antibodi
also
abl
pass
placenta
infect
due
chikungunya
viru
pregnanc
seriou
nonpregn
woman
although
direct
compar
studi
even
though
viru
cross
placenta
second
third
trimest
fetal
infect
miscarriag
rare
high
risk
vertic
transmiss
hand
mother
infect
day
deliveri
evid
zika
viru
infect
manifest
virul
form
pregnanc
consequ
fetu
howev
depend
trimest
higher
risk
neurolog
complic
associ
first
second
trimest
main
consequ
microcephali
intracrani
calcif
cerebellar
abnorm
dysgenesi
corpu
callosum
eye
abnorm
among
airborn
infect
transmit
influenza
present
respiratori
complic
pregnant
woman
higher
rate
mortal
especi
third
trimest
also
lead
miscarriag
prematur
birth
although
caus
fetopathi
sar
mer
coronavirus
caus
rapid
respiratori
failur
high
mortal
rate
among
expect
mother
high
number
miscarriag
prematur
birth
pregnant
woman
avoid
postpon
travel
area
malaria
endem
particularli
p
falciparum
resist
travel
avoid
essenti
take
everi
precaut
use
effect
chemoprophylaxi
immunoprophylaxi
live
attenu
vaccin
contain
weaken
form
bacteria
virus
contraind
possibl
except
yellow
fever
vaccin
case
risk
high
although
rare
travel
immunoglobulin
prophylaxi
consid
safe
may
given
follow
exposur
certain
infect
chiefli
rabi
prevent
malaria
drug
choic
chloroquin
area
plasmodium
spp
chloroquinesensit
chloroquineproguanil
area
resist
even
though
data
show
take
mefloquin
increas
risk
teratogen
effect
recommend
continu
take
pregnanc
chemoprophylaxi
atovaquoneproguanil
recommend
effect
fetu
unknown
doxycyclin
contraind
teratogen
effect
fetu
specif
comment
may
made
concern
treatment
import
infect
pregnant
women
travel
diarrhea
treat
promptli
appropri
oral
hydrat
antiemet
metoclopramid
antidiarrh
loperamid
may
given
clinic
indic
azithromycin
antimicrobi
choic
diarrhea
pregnanc
quinolon
use
contraind
ii
azithromycin
treatment
choic
pregnant
travel
typhoid
fever
iii
although
treatment
intestin
parasit
may
postpon
establish
metronidazol
use
first
trimest
pregnanc
paromomycin
throughout
pregnanc
iv
treat
malaria
pregnant
travel
publish
previous
journal
v
manag
dengu
conserv
support
treatment
monitor
hematolog
statu
neonat
vi
approach
possibl
infect
zika
viru
pregnanc
ongo
review
princip
avoid
consequ
neonat
travel
diarrhea
immunecompromis
patient
broader
differenti
diagnosi
increas
proport
case
caus
intestin
protozoa
cryptosporidium
spp
cystoisospora
belli
cyclospora
cayetanensi
patient
diarrhea
wateri
tend
becom
chronic
even
fulmin
diarrhea
diagnosi
parasitolog
stool
test
use
modifi
kinyoun
stain
acidfast
bacilli
essenti
view
coccidian
oocyst
infect
caus
helminth
strongyloidiasi
deserv
special
mention
although
instanc
gener
asymptomat
mild
symptom
progress
immunocompromis
individu
sever
form
hyperinfest
syndrom
dissemin
strongyloidiasi
frequent
associ
corticosteroid
therapi
transplant
coinfect
mortal
around
although
clinic
pictur
basic
report
immigr
popul
also
observ
travel
treatment
choic
sever
case
ivermectin
dose
day
day
symptom
ceas
melioidosi
bacteri
infect
caus
burkholderia
pseudomallei
caus
pneumonia
sepsi
mainli
found
certain
asian
australian
region
patient
typic
risk
factor
meliodiasi
diabet
mellitu
one
mainli
associ
although
immun
suppress
condit
favour
appear
histoplasmosi
endem
mycosi
primarili
affect
lung
although
immunocompromis
patient
especi
report
hivinfect
individu
may
manifest
dissemin
varieti
mycosi
endem
mani
area
america
africa
asia
acquir
travel
endem
mycos
dissemin
complic
immunosuppress
travel
coccidioidomycosi
paracoccidioidomycosi
dissemin
southeast
asia
hiv
infect
